Another report [135] confirmed the involvement of ALKBH5 in the pathogenesis of SLE, as its levels were significantly decreased compared to patients with other diseases (rheumatoid arthritis, hepatitis B virus-infected patients, and tuberculosis patients [135]). Here, ALKBH5 is linked to systemic lupus erythematosus.